ITEOS THERAPEUTICS IN

iTeos Reports Third Quarter 2023 Financial Results and Provides Business Updates

07 11月 2023 06:00:00 条件 Nasdaq GlobeNewswire

iTeos to Participate in Upcoming Investor Conferences

06 9月 2023 06:00:00 条件 Nasdaq GlobeNewswire

iTeos Reports Second Quarter 2023 Financial Results and Provides Business Updates

08 8月 2023 06:00:01 条件 Nasdaq GlobeNewswire

iTeos Reports First Quarter 2023 Financial Results and Provides Business Updates

10 5月 2023 06:01:00 条件 Nasdaq GlobeNewswire

iTeos Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates

15 3月 2023 06:00:00 条件 Nasdaq GlobeNewswire

iTeos to Present at SVB Securities Global Biopharma Conference

07 2月 2023 06:00:01 条件 Nasdaq GlobeNewswire

iTeos Provides Business Updates and Clinical Development Plans for 2023

09 1月 2023 06:00:02 条件 Nasdaq GlobeNewswire

iTeos to Present at the 41st Annual J.P. Morgan Healthcare Conference

03 1月 2023 06:00:01 条件 Nasdaq GlobeNewswire

iTeos to Present at the Piper Sandler 34th Annual Healthcare Conference

22 11月 2022 06:00:00 条件 Nasdaq GlobeNewswire

iTeos Reports Third Quarter 2022 Financial Results and Provides Business Updates

10 11月 2022 15:01:00 条件 Nasdaq GlobeNewswire

iTeos Reports Second Quarter 2022 Financial Results and Provides Business Update

10 8月 2022 15:01:00 条件 Nasdaq GlobeNewswire

iTeos to Present at the 2022 Wedbush PacGrow Healthcare Conference

02 8月 2022 06:00:01 条件 Nasdaq GlobeNewswire

iTeos Reports First Quarter 2022 Financial Results and Provides Business Update

12 5月 2022 15:01:00 条件 Nasdaq GlobeNewswire

iTeos Presents New Data for Anti-TIGIT Antibody, EOS-448/GSK4428859A, at the AACR Annual Meeting 2022

08 4月 2022 12:00:00 条件 Nasdaq GlobeNewswire

iTeos Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

23 3月 2022 15:01:00 条件 Nasdaq GlobeNewswire

iTeos to Present at the Cowen 42nd Annual Health Care Conference

01 3月 2022 06:00:01 条件 Nasdaq GlobeNewswire

iTeos to Participate in Upcoming Investor Conferences in February

10 2月 2022 06:00:01 条件 Nasdaq GlobeNewswire

iTeos Provides Clinical Development Plans and Promotes Yvonne McGrath, Ph.D. to Chief Scientific Officer

10 1月 2022 06:00:02 条件 Nasdaq GlobeNewswire

iTeos to Present at the 40th Annual J.P. Morgan Healthcare Conference

03 1月 2022 15:01:00 条件 Nasdaq GlobeNewswire

iTeos Announces New Data for its Anti-TIGIT Antibody, EOS-448, at the American Society of Hematology Annual Meeting and TIGIT Therapies Digital Summit 2021

09 12月 2021 15:01:00 条件 Nasdaq GlobeNewswire